At Bay Area Lyme Foundation, we are excited about the potential for significant breakthroughs in medical research being led by the following scientists.

John N. Aucott, MD

Dr. Aucott is an Associate Professor of Medicine in the Division of Rheumatology at Johns Hopkins University Medical School and the Director of the Johns Hopkins Lyme Disease Research Center

Dr. Aucott is a renowned expert in clinical research on the diagnosis and epidemiology of Lyme disease. He is the founder and president of Lyme Disease Research Foundation, a public nonprofit organization founded to promote research and education in Lyme disease.


Alan Barbour, MD

Professor of Medicine and Microbiology & Molecular Genetics, School of Medicine, UC Irvine

Dr. Barbour is a pioneer in the Lyme disease field who worked with Willy Burgdorfer to identify the cause of Lyme and was the first to isolate and grow the Borrelia burgdorferi bacteria in a laboratory. He is currently focused on understanding genes that are involved in the persistence of infection or inflammation.


Chase Beisel

Chase Beisel, PhD

Assistant Professor, Department of Chemical & Biomolecular Engineering, North Carolina State University.

Dr Chase Beisel was awarded the 2016 Emerging Leader Award to explore the potential ability of CRISPR-Cas genome targeting to kill the bacteria that causes Lyme.


Lisa K. Blum, PhD

Lisa K. Blum, PhD

Postdoc Fellow, Stanford University School of Medicine (Immunology & Rheumatology)

Dr. Blum is a 2014 Bay Area Lyme Foundation Emerging Leader Award winner and fellow at Stanford University in the laboratory of Dr. William Robinson, where she is currently working on DNA sequencing of human antibody responses to Borrelia burgdorferi infection.


Jerome F. Bouquet, PhD

Jerome F. Bouquet, PhD

Postdoc Fellow, University of California, San Francisco (Microbiology)

Dr. Bouquet is a 2014 Bay Area Lyme Foundation Emerging Leader Award winner and fellow at UCSF in the laboratory of Dr. Charles Chiu studying infectious disease, particularly Lyme and other tick-borne illnesses.


John A. Branda, MD

Assistant Professor, Harvard Medical School and Assistant Pathologist, Massachusetts General Hospital (MGH)

Dr. Branda's research focuses on improving patient care through the development of new diagnostic strategies and the optimization of laboratory tests and antimicrobial agents, including tick-borne illnesses such as Lyme borreliosis, anaplasmosis, and tularemia.


Charles Chiu

Charles Chiu, MD, PhD

Professor of Laboratory Medicine and Medicine, Division of Infectious Diseases at University of California, San Francisco, Director of the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC), and Associate Director of the UCSF Clinical Microbiology Laboratory.

Dr. Chiu is an expert in the development and implementation of advanced genomic technologies for pathogen discovery and clinical diagnostics including microarrays and next generation sequencing.


James J. Collins, PhD

Core Faculty, Wyss Institute, Harvard University; Termeer Professor of Medical Engineering & Science; Professor of Biological Engineering, Massachusetts Institute of Technology

Dr. James Collins is a 2017 Bay Area Lyme Foundation Emerging Leader Award winner. He is recognized for his pioneering research in synthetic biology and systems biology.


Matt Croughan, PhD

Biotechnology Industry Consultant

Dr. Croughan is an expert in process development and manufacturing for biopharmaceutical, cell therapy, and biofuels.


Monica E. Embers, PhD

Assistant Professor, Division of Bacteriology and Parasitology, Tulane National Primate Research Center, Tulane University School of Medicine

Dr. Embers' work focuses on antibiotic efficacy against Lyme disease; and immunodiagnosis for the Lyme-causing B. burgdorferi infection.


Mark Eshoo

Mark Eshoo, PhD

Director, New Technology Development, Ibis Biosciences, Inc.

Dr. Eshoo serves as the Director of New Technology Development at Ibis Biosciences where he leads several projects relating to development and assessment of new diagnostic technologies.


Nichola C. Garbett, PhD

Nichola C. Garbett, PhD

Assistant Professor, University of Louisville School of Medicine; Assistant Director of the Biophysical Core Facility, James Graham Brown Cancer Center, University of Louisville

Dr. Garbett applies biophysical approaches to the study of biomolecules and their interactions, with particular emphasis on the development of new technologies for medical diagnostics and drug development.


Eva Garland

Eva Garland, PhD

Vice President of Research & Development, Agile Sciences

Dr. Garland has been leading the research efforts at Agile Sciences focused on a new treatment attacking the biofilms that surround the borrelia burgdorferi bacteria protecting it from human immunological response.


Andrea Granados, PhD

Postdoctoral Fellow, Department of Laboratory Medicine, University of California, San Francisco School of Medicine

Dr. Granados is a 2019 Bay Area Lyme Foundation Emerging Leader Award winner. She is studying differential gene response in early Lyme disease and other tick-borne infections. Dr. Granados is Postdoctoral Fellow at UCSF School of Medicine.


Britton Grasperge

Britton J. Grasperge, PhD

Assistant Professor - Clinical Pathology, Louisiana State University

Dr. Britton Grasperge is a 2016 Emerging Leader Award recipient and a veterinary clinical pathologist with a research interest in tick-borne diseases.


Emir Hodzic, DVM, PhD

Emir Hodzic, DVM, PhD

Director, Real-Time PCR Research & Diagnostics Core Facility, School of Veterinary Medicine, University of California, Davis

Dr. Emir Hodzic received Veterinary, Masters and Ph.D. degrees from University of Sarajevo, School of Veterinary Medicine, Bosnia and Herzegovina. He did postdoctoral training at the Section of Comparative Medicine, Yale University School of Medicine where he focused on animal models for Lyme disease and human granulocytic ehrlichiosis. Currently, Dr. Hodzic is a Director at the Real-Time PCR Research & Diagnostics Core Facility at the School of Veterinary Medicine, University of California, Davis where he is researching post-antibiotic persistence of Borrelia burgdorferi.


Lee Hood

Lee Hood, MD, PhD

President and Co-Founder of the Institute for Systems Biology

Dr. Hood's outstanding contributions have had a resounding effect on the advancement of science since the 1960s. He has made many seminal discoveries in the fields of immunology, neurobiology and biotechnology and, most recently, systems biology and its applications to cancer and neurodegenerative disease.


Liz Horn

Liz Horn, PhD, MBI

Principal, LHC Biosolutions

Dr. Horn facilitates the development of biorepositories and other bio-based technologies for medical research and is the Principal Investigator for the new National Lyme Biorepository.


Richard Horowitz, MD

Medical Director, Hudson Valley Healing Arts Center

Dr. Richard Horowitz is a board certified internist in private practice in Hyde Park, N.Y. He is medical director of the Hudson Valley Healing Arts Center, an integrative medical center which combines both classical and complementary approaches in the treatment of Lyme Disease and other tick-borne disorders. He has been treating Lyme patients for the last 29 years, and he is now undertaking a data mining project with support of Bay Area Lyme Foundation.


A.T. Charlie Johnson, PhD

Professor of Physics, University of Pennsylvania

Dr. Johnson is currently developing a new Lyme diagnostic using single-layered molecular graphene sheets attached to antibodies to identify specific proteins carried by the Borrelia burgorferi bacteria.


Anthony D. Long, PhD

Professor of Ecology and Evolutionary Biology, UC Irvine

Dr. Long is applying his expertise in model systems to understand genes that influence the body’s response to the Lyme bacteria, Borrelia burgdorferi.   


Jennifer Miller, PhD

Contractor, Agile Sciences

Dr. Miller has studied the Lyme disease spirochete Borrelia burgdorferi for her entire 15-year career. Her work focuses on the pathogenesis of B. burgdorferi and its interactions with the host immune system. She is currently employed by Agile Sciences.


Yuko Nakajima, PHD

Postdoctoral Fellow, Brandeis University

Dr. Nakajima is a 2017 Bay Area Lyme Foundation Emerging Leader Award winner and postdoctoral fellow at Brandeis University in the lab of James E. Haber, where she is studying gene conversion to block immune evasion by Borrelia burgdoferi and other pathogens.


Nate Nieto, PhD

Assist. Professor, Northern Arizona University

Dr. Nieto's research focus is on infectious diseases, vector biology, and the ecological evolution and transmission of disease from wildlife to humans and domestic animals.


Lise Nigrovic

Lise E. Nigrovic, MD, MPH

Associate Professor of Pediatrics and Emergency Medicine, Harvard Medical School and Director of Education, Clinical Research Center and Senior Associate Physician in Medicine at Boston Children’s Hospital

Dr. Lise E. Nigrovic is the Director of Education, Clinical Research Center and Senior Associate Physician in Medicine at Boston Children’s Hospital and an Associate Professor of Pediatrics and Emergency Medicine at Harvard Medical School. Her current work is focused on a pediatric multi‐center Lyme disease research network with biosample collection.


Geetha Parthasarathy, PhD

Research Scientist, Tulane University

Dr. Parthasarathy is a 2019 Bay Area Lyme Foundation Emerging Leader Award winner. She is studying pathogenesis behind glial and neuronal cell death as caused by B. burgdorferi. Dr. Parthasarathy is a Research Scientist at Tulane University.


Nira Pollock, MD, PhD

Assistant Professor, Harvard Medical School, and Associate Medical Director of the Infectious Diseases Diagnostic Laboratory at Boston Children's Hospital

Dr. Pollock's research has a special interest on the development and evaluation of novel diagnostic tests for infectious diseases and related applications. Her Lyme-related work has included the discovery of novel biomarkers of early Lyme borreliosis.


Nathan Price

Nathan Price, PhD

Assoc. Director of the Institute for Systems Biology; Affiliate Faculty in Bioengineering, Computer Science & Engineering, and Molecular & Cellular Biology, Univ. of Washington

Dr. Price has won numerous awards including an American Cancer Society Postdoctoral Fellowship, a NIH Howard Temin Pathway to Independence Award, a NSF CAREER award, and a young investigator award from the Roy J. Carver Charitable Trust.


Jayakumar Rajadas

Jayakumar Rajadas, PhD

Jayakumar Rajadas, PhD Director Biomaterials and Advanced Drug Delivery Laboratory Stanford University School of Medicine Stanford, CA and Professor(Adjunct) Bioengineering and Therapeutic Sciences UCSF School of Pharmacy University of California, San Francisco, CA

Dr. Rajadas is Director of the Biomaterials and Advanced Drug Delivery Lab (BioADD) and Assistant Director of Cardiovascular Pharmacology at Stanford School of Medicine. His recent research, funded by Bay Area Lyme Foundation, identified 20 FDA-approved compounds that were more effective in inhibiting persistent Lyme bacteria than standard antibiotic treatment.


William Robinson

William Robinson, MD, PhD

Professor of Medicine and Chief of the Division of Immunology & Rheumatology

Dr. Robinson works to develop novel therapies for practical patient care, including the application of antibody sequencing technologies for the treatment of Lyme and other autoimmune diseases.


Pardis Sabeti, MD, DPhil

Professor, Systems Biology and Organismic and Evolutionary Biology, Harvard University; Professor, Immunology and Infectious Disease, Harvard Chan School of Public Health; Howard Hughes Medical Institute and the Broad Institute of Harvard and MIT

Dr. Pardis Sabeti is a Professor at the Center for Systems Biology and Department of Organismic and Evolutionary Biology at Harvard University and a Professor in the Department of Immunology and Infectious Disease at the Harvard School of Public Health. She is an Institute Member of the Broad Institute of Harvard and MIT as well as a Howard Hughes Investigator. Dr. Sabeti is using gene sequencing techniques to study co-infections associated with Lyme disease.


Daniel Salkeld

Daniel Salkeld, PhD

Research Scientist, Colorado State University

Dr. Salkeld is a Research Scientist at Colorado State University and has worked extensively on California tick-borne diseases.


Mark Soloski

Mark Soloski, PhD

Professor, Johns Hopkins University School of Medicine (Rheumatology, Molecular Biology & Genetics, and Molecular Biology)

Dr. Soloski is a co-Principal Investigator on the landmark SLICE clinical trial and specializes in the study of certain immune cells (T-cells) and their role in immune recognition, autoimmunity, and host response to infection in acute and chronic disease states.


Andrea Swei

Andrea Swei, PhD

Assistant Professor, San Francisco State University

Dr. Swei’s research seeks to better understand how different Borrelia burgdorferi genotypes are transmitted and maintained in natural tick populations. The ultimate goal of Dr. Swei’s research is to better understand the factors that lead to the distribution and risk of important tick-borne diseases to human populations.


Ying Zhang, MD

Professor at Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health

Dr. Ying Zhang is a Professor at Department of Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health. His recent research efforts have included developing more effective treatments for persistent Lyme disease and associated conditions.


Yong Zhou, Ph.D.

Research Scientist, Institute for Systems Biology

Dr. Zhou is a Research Scientist at the Institute for Systems Biology (ISB), where he is working on a number of biomarker discovery projects.